Stephen Y Lai Selected Research

Erythropoietin Receptors (Erythropoietin Receptor)

1/2016	Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
11/2012	A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).
6/2010	Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
2/2008	Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
10/2006	Understanding the presence and function of erythropoietin receptors on cancer cells.
5/2005	Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Y Lai Research Topics

Disease

84	Neoplasms (Cancer) 01/2022 - 03/2002
24	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 05/2005
21	Squamous Cell Carcinoma of Head and Neck 06/2020 - 03/2004
13	Oropharyngeal Neoplasms 01/2022 - 11/2013
11	Deglutition Disorders (Dysphagia) 11/2019 - 11/2013
8	Anaplastic Thyroid Carcinoma 01/2019 - 04/2011
6	Osteoradionecrosis 10/2021 - 11/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 11/2009
6	Anemia 11/2012 - 05/2005
5	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2009
5	Carcinoma (Carcinomatosis) 01/2017 - 07/2010
4	Papillary Thyroid Cancer 01/2021 - 07/2010
4	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2020 - 11/2018
4	Thyroid Neoplasms (Thyroid Cancer) 12/2017 - 07/2010
3	Xerostomia 01/2022 - 07/2015
3	Hypoxia (Hypoxemia) 12/2015 - 03/2004
2	Fatigue 01/2022 - 06/2005
2	Hypesthesia (Numbness) 01/2021 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
2	Aspiration Pneumonia 11/2019 - 01/2017
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018 - 12/2016
2	Hematologic Neoplasms (Hematological Malignancy) 03/2017 - 06/2010
2	Infections 01/2015 - 11/2012
1	Lymphadenopathy 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Tonsillar Neoplasms 01/2022
1	Trismus (Lockjaw) 04/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Nausea 01/2021
1	Mucositis 01/2021
1	Glioma (Gliomas) 01/2019
1	Circulating Neoplastic Cells 09/2018
1	Hypothyroidism 06/2018
1	medullary Thyroid cancer 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Extranodal Extension 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2010
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2010
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2009
6	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016 - 05/2005
5	Pyruvic Acid (Pyruvate)IBA 01/2018 - 05/2015
4	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2013
4	Erythropoietin FDA Link 11/2012 - 05/2005
4	HematinicsIBA 11/2012 - 02/2008
3	Pharmaceutical PreparationsIBA 10/2021 - 07/2010
3	Cetuximab (Erbitux)FDA Link 01/2021 - 01/2010
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 03/2017
3	Immune Checkpoint InhibitorsIBA 12/2018 - 11/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 12/2015
3	Biological ProductsIBA 01/2017 - 06/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	PlatinumIBA 01/2021 - 03/2017
2	Docetaxel (Taxotere)FDA Link 01/2021 - 12/2010
2	RadiopharmaceuticalsIBA 01/2019 - 10/2015
2	BariumIBA 01/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 01/2016
2	Long Noncoding RNAIBA 02/2016 - 02/2016
2	IodineIBA 01/2016 - 07/2015
2	Transcription Factors (Transcription Factor)IBA 07/2010 - 03/2004
2	Janus KinasesIBA 06/2010 - 06/2005
1	ferric oxide (iron oxide)IBA 01/2021
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2021
1	10-propargyl-10-deazaaminopterin FDA Link 01/2021
1	PanobinostatIBA 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Contrast MediaIBA 01/2020
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020
1	GadoliniumIBA 01/2020
1	fluciclovine F-18IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	trametinibIBA 01/2019
1	dabrafenibIBA 01/2019
1	NivolumabIBA 11/2018
1	IpilimumabIBA 11/2018
1	Edetic Acid (EDTA)FDA Link 09/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017
1	Cell-Free Nucleic AcidsIBA 01/2017

Therapy/Procedure

54	Radiotherapy 01/2022 - 03/2004
22	Therapeutics 01/2021 - 05/2005
17	Drug Therapy (Chemotherapy) 10/2021 - 06/2005
9	Chemoradiotherapy 01/2022 - 07/2010
7	Enteral Nutrition (Feeding, Tube) 04/2021 - 11/2013
7	Aftercare (After-Treatment) 01/2021 - 11/2013
7	Neck Dissection (Radical Neck Dissection) 11/2019 - 12/2007
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2017
4	Induction Chemotherapy 01/2021 - 11/2013
4	Gastrostomy 01/2017 - 11/2013
2	Proton Therapy 12/2021 - 01/2017
2	Tracheostomy 11/2019 - 03/2002
2	Oral Administration 12/2012 - 07/2010
1	Operative Surgical Procedures 01/2020
1	Airway Management 01/2020
1	Image-Guided Radiotherapy 11/2018
1	Drug Tapering 11/2018
1	Laryngectomy 01/2017